Mesenchymal stromal cells as carriers of IL-12 reduce primary and metastatic tumors of murine melanoma
Abstract Due to immunosuppressive properties and confirmed tropism towards cancer cells mesenchymal stromal cells (MSC) have been used in many trials. In our study we used these cells as carriers of IL-12 in the treatment of mice with primary and metastatic B16-F10 melanomas. IL-12 has confirmed ant...
Enregistré dans:
Auteurs principaux: | Natalia Kułach, Ewelina Pilny, Tomasz Cichoń, Justyna Czapla, Magdalena Jarosz-Biej, Marek Rusin, Alina Drzyzga, Sybilla Matuszczak, Stanisław Szala, Ryszard Smolarczyk |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/bcd4d466f3a84e96830b0f5ae3e9063f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Combination of anti-vascular agent - DMXAA and HIF-1α inhibitor - digoxin inhibits the growth of melanoma tumors
par: Ryszard Smolarczyk, et autres
Publié: (2018) -
Outstanding Response to Sorafenib in a Patient with Metastatic Gastrointestinal Stromal Tumour
par: Charlotte Brinch, et autres
Publié: (2021) -
Stromal and epithelial transcriptional map of initiation progression and metastatic potential of human prostate cancer
par: Svitlana Tyekucheva, et autres
Publié: (2017) -
Przydrożne sacrum w pamięci lokalnej
par: Stanisław Szczepan Cichoń
Publié: (2020) -
Metabolic reprogramming underlies metastatic potential in an obesity-responsive murine model of metastatic triple negative breast cancer
par: Ciara H. O’Flanagan, et autres
Publié: (2017)